Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...

The team at Zucker Hillside Hospital on the Queens-Nassau border will be administering cannabis, MDMA, commonly know as ecstasy or molly, and psilocybin, a compound in so-called "magic mushrooms." ...

At 15 years old, Danny Motyka dreamed of one day opening a psychedelics drug lab.

It's been 60-plus years since the Harvard Psilocybin Project, the rise of hippie communes, and the psychedelic era. Now some baby boomers are returning to the drugs of their youth — to confront aging.

Casey Means thinks improving health is a spiritual project.

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

Altman’s campaigning for his company coincides with its use of enormous present resources to serve an imagined future ...

Neuroscientist Ben Rein is on a mission to show that being around others not only feels good, but can even improve recovery from strokes, cancer and heart attacks. So why are so many of us isolated ...

As of Friday, January 23, Relmada Therapeutics, Inc.’s RLMD share price has surged by 7.58%, which has investors questioning if this is right time to sell.

The ASX drifted lower on Wednesday morning, as Wall Street softened on easing inflation, while oil fears lifted energy stocks ...

NH legalization hearing; WA medical marijuana in hospitals; Alcohol coalition on hemp drinks; Study: 10M Americans microdosed ...

GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...